EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Activatable Nanoradiosensitizer for Second Near‐Infrared Fluorescence Imaging‐Guided Safe‐Dose Synergetic Chemo‐Radiotherapy of Rheumatoid Arthritis

Yarong Jin, Dongsheng Li, Xiaochun Zheng, Mengting Gao, Wenxuan Wang, Xin Zhang, Weiwei Kang, Chongqing Zhang, Shutong Wu, Rong Dai, Ziliang Zheng, Ruiping Zhang iD

Advanced Science · 2024

DOI: 10.1002/advs.202308905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yarong Jin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Fifth Hospital of Shanxi Medical University (Shanxi Provincial People's Hospital), Taiyuan, 030000, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Indocyanine Green, Optical Imaging, Cisplatin. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province, Central Guiding Local Science and Technology Development Fund Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The precise theranostics of rheumatoid arthritis (RA) remains a formidable challenge in clinical practice. Exploring novel applications of contemporary therapeutic approaches like chemo‐radiotherapy is promising as a highly effective strategy for RA. Herein, a novel activatable nanoradiosensitizer‐40 (denoted as IRnR‐40) is developed, based on encapsulating the clinically approved drugs cisplatin (DDP) and indocyanine green (ICG) within a gelatin shell to achieve second near‐infrared fluorescence (NIR‐II FL) imaging‐guided safe‐dose synergetic chemo‐radiotherapy. The high concentration of matrix metalloproteinase‐9 (MMP‐9) in the RA microenvironment plays a pivotal role in triggering the responsive degradation of IRnR‐40, leading to the rapid release of functional molecules DDP and ICG. The released ICG serves the dual purpose of illuminating the inflamed joints to facilitate accurate target volume delineation for guiding radiotherapy, as well as acting as a real‐time reporter for quantifying the release of DDP to monitor efficacy. Meanwhile, the released DDP achieves highly effective synergistic chemotherapy and radiosensitization for RA via the dual reactive oxygen species (ROS)‐mediated mitochondrial apoptotic pathway. To sum up, this activatable nanoradiosensitizer IRnR‐40 is believed to be the first attempt to achieve efficient NIR‐II FL imaging‐guided safe‐dose chemo‐radiotherapy for RA, which provides a new paradigm for precise theranostics of refractory benign diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidIndocyanine GreenOptical ImagingCisplatinAnimalsMiceDisease Models, AnimalRadiation-Sensitizing AgentsHumansChemoradiotherapy

Stichwörter der Autor:innen

activatable nanoradiosensitizerlow‐dose radiotherapyrheumatoid arthritissecond near‐infrared fluorescence imaging

Substanzen

Indocyanine GreenCisplatinRadiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Radiology, Fifth Hospital of Shanxi Medical University (Shanxi Provincial People's Hospital), Taiyuan, 030000, China.
  • Research Team of Molecular Medicine, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, China.
  • Department of Orthopedics, Third Hospital of Shanxi Medical University (Shanxi Bethune Hospital), Taiyuan, 030032, China.
  • Department of Radiology, Shanxi Province Cancer Hospital (Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University), Taiyuan, 030013, Chi…

ORCID-Profile: Ruiping Zhang

Förderung

  • National Natural Science Foundation of China
  • Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province
  • Central Guiding Local Science and Technology Development Fund Projects
  • China Postdoctoral Science Foundation
  • Four Batches of Scientific Research Projects of Shanxi Provincial Health Commission
  • Research Project Supported by Shanxi Scholarship Council of China
  • Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province
  • Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi

Zitieren

APA

Jin, Y., Li, D., Zheng, X., Gao, M., Wang, W., Zhang, X., Kang, W., Zhang, C., Wu, S., Dai, R., Zheng, Z., & Zhang, R. (2024). A Novel Activatable Nanoradiosensitizer for Second Near‐Infrared Fluorescence Imaging‐Guided Safe‐Dose Synergetic Chemo‐Radiotherapy of Rheumatoid Arthritis. Advanced Science. https://doi.org/10.1002/advs.202308905

Vancouver

Jin Y, Li D, Zheng X, Gao M, Wang W, Zhang X, et al. A Novel Activatable Nanoradiosensitizer for Second Near‐Infrared Fluorescence Imaging‐Guided Safe‐Dose Synergetic Chemo‐Radiotherapy of Rheumatoid Arthritis. Advanced Science. 2024. doi:10.1002/advs.202308905

BibTeX
@article{Jin2024,
  author = {Jin, Yarong and Li, Dongsheng and Zheng, Xiaochun and Gao, Mengting and Wang, Wenxuan and Zhang, Xin and Kang, Weiwei and Zhang, Chongqing and Wu, Shutong and Dai, Rong and Zheng, Ziliang and Zhang, Ruiping},
  title = {A Novel Activatable Nanoradiosensitizer for Second Near‐Infrared Fluorescence Imaging‐Guided Safe‐Dose Synergetic Chemo‐Radiotherapy of Rheumatoid Arthritis},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308905}
}
Kostenlos starten →